Tracking and protection of transplanted stem cells using a Ferrocenecarboxylic acid (cas 1271-42-7)-conjugated peptide that mimics hTERT

Add time:08/13/2019    Source:sciencedirect.com

In vivo tracking of transplanted stem cells has been a central aim of stem cell therapy. Although many tracking systems have been introduced, no method has yet been validated for clinical applications. We developed a novel sophisticated peptide (GV1001) that mimics hTERT (human telomerase reverse transcriptase) and analysed its ability to track and protect stem cells after transplantation. Ferrocenecarboxylic acid-conjugated GV1001 (Fe-GV1001) efficiently penetrated stem cells with no adverse effects. Moreover, Fe-GV1001 improved the viability, proliferation, and migration of stem cells under hypoxia. After Fe-GV1001-labelled stem cells were transplanted into the brains of rats after stroke, the labelled cells were easily tracked by MRI. Our findings indicate that Fe-GV1001 can be used for the in vivo tracking of stem cells after transplantation into the brain and can improve the efficacy of stem cell therapy by sustaining and enhancing stem cell characteristics under disease conditions.

We also recommend Trading Suppliers and Manufacturers of Ferrocenecarboxylic acid (cas 1271-42-7). Pls Click Website Link as below: cas 1271-42-7 suppliers

Prev:Hierarchy concomitant in situ stable iron(II)−carbon source manipulation using Ferrocenecarboxylic acid (cas 1271-42-7) for hydrothermal synthesis of LiFePO4 as high-capacity battery cathode
Next:Reactions of allylzinc bromide with ETHYNYLFERROCENE (cas 1271-47-2) derived fluorinated cyclophosphazenes)